Argireline and SNAP-8 are closely related cosmetic peptides that work the same way: both target the SNARE complex to soften the appearance of expression lines, the "topical Botox" idea. SNAP-8 (acetyl octapeptide) is essentially an extended version of Argireline (acetyl hexapeptide), marketed as a refinement. Both are topical cosmetic ingredients with modest effects.
At a glance
| Argireline | SNAP-8 | |
|---|---|---|
| Type | Acetyl hexapeptide | Acetyl octapeptide (extended) |
| Mechanism | SNARE-targeting (expression lines) | SNARE-targeting (expression lines) |
| Relationship | The original | Longer-chain refinement of the same idea |
| Regulation | Cosmetic ingredient | Cosmetic ingredient |
| Effect size | Modest, gradual | Modest, gradual |
| Route | Topical | Topical |
The bottom line
Bottom line: Two versions of the same idea. Both target the SNARE complex to soften movement lines, with SNAP-8 being a longer peptide marketed as an improved Argireline. Real-world differences are subtle, both are cosmetics with modest gradual effects, and neither rivals injected botulinum toxin.
Frequently asked questions
What's the difference between Argireline and SNAP-8?
Both are SNARE-targeting cosmetic peptides aimed at softening expression lines. SNAP-8 (acetyl octapeptide) is essentially a longer-chain extension of Argireline (acetyl hexapeptide), marketed as a refinement. Their effects are similar and modest.
Are they like Botox?
They are marketed as 'topical Botox' because they target the same SNARE signaling pathway, but as topical cosmetics their effects are far milder and more gradual than injected botulinum toxin.
Which works better?
Differences between Argireline and SNAP-8 are subtle; both are cosmetic ingredients with modest, cumulative effects. Neither is a drug or a substitute for medical treatments.
References
Combined peer-reviewed sources from both peptide guides. Inclusion is not endorsement.
- Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002. Peer-reviewed study
- Lim SH, Sun Y, Madanagopal TT, et al. Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification. Sci Rep. 2018. Peer-reviewed study
- Velazco de Maldonado GJ, Suárez-Vega DV, Miller-Kobisher B, et al. Polydioxanone Bioactive Sutures-Acetyl Hexapeptide-8 (Argireline): An Intelligent System for Controlled Release in Facial Harmonization. J Cutan Aesthet Surg. 2023. Peer-reviewed study
- Wang Y, Wang M, Xiao S, et al. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study. Am J Clin Dermatol. 2013. Peer-reviewed study
- Chen CF, Liu J, Wang SS, et al. Mycobacterium abscessus infection after facial injection of argireline: A case report. World J Clin Cases. 2021. Peer-reviewed study
- Kluczyk A, Ludwiczak J, Modzel M, et al. Argireline: Needle-Free Botox as Analytical Challenge. Chem Biodivers. 2021. Peer-reviewed study
- Robinson LR, Fitzgerald NC, Doughty DG, et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005. Peer-reviewed study
- Praissman M, Fara JW, Praissman LA, et al. Preparation of an N-acetyl-octapeptide of cholecystokinin. The role of N-acetylation in protecting the octapeptide from degradation by smooth muscle tissues. Biochim Biophys Acta. 1982. Peer-reviewed study
- Knight M, Tamminga CA, Steardo L, et al. Cholecystokinin-octapeptide fragments: binding to brain cholecystokinin receptors. Eur J Pharmacol. 1984. Peer-reviewed study
- Malbarba A, Ciabatti R, Scotti R, et al. Octapeptide derivatives of teicoplanin antibiotics. J Antibiot (Tokyo). 1993. Peer-reviewed study
- Mondal P, Das G, Khan J, et al. Crafting of Neuroprotective Octapeptide from Taxol-Binding Pocket of β-Tubulin. ACS Chem Neurosci. 2018. Peer-reviewed study